foxo4-dri senolytic or senomorphic

foxo4-dri senolytic or senomorphic Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Class II senolytics inhibit survival

Name: foxo4-dri senolytic or senomorphic Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Class II senolytics inhibit survival
Brand: sitebuilder.ws
SKU: 2661580192
Price: 24.09 USD
Availability: InStock
Rating: 4.8586 (29 reviews)

SKU: 2661580192

4.9

USD24.09 USD53.09

Pay in 4 interest-free payments of $6.02 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

The International journal of neuroscience , 37 1-2, 85-8

In stock Purchase & earn 20 points

Maintenance: After initiation and optimization, your physician should have dialed in your dose for the best results

While clinical development for obesity was discontinued in 2007 after a Phase IIb trial failed to achieve its primary endpoint, the peptide remains a valuable research tool for investigating adipose tissue biology, lipolytic pathways, and receptor-independent signaling mechanisms